Top Tweets for #BESREMI
BESREMi is now FDA approved for adults with #essentialthrombocythemia (ET).
What should patients know? My PV Reporter article covers trial results, dosing, safety, and questions for your hematologist.
https://t.co/fDt7D77Y5J
#bloodcancerawarenessmonth #BESREMi #pvreporter
Congratulations to Dr. Nikolai Podolsev @YaleHematology, whose leadership of a #clinicaltrial at Smilow Cancer Hospital resulted in FDA approval of #Besremi (#ropeginterferon) for treatment of #essentialthrombocythemia (ET).
https://t.co/SKX21FaFBk
@SmilowCancer
❗ The #FDA has approved @PharmaEssentia’s #BESREMi for adults with #EssentialThrombocythemia, regardless of genotype or disease status.
✅ The agent was previously approved for certain adults with #PolycythemiaVera earlier this year. https://t.co/FP069LBRjN
🩸A new option for essential thrombocythemia.
With #Besremi (#ropeginterferon alfa-2b) now #FDA-approved for adults with ET, Phase 3 data point to a durable response advantage over anagrelide.
#EssentialThrombocythemia #FDAApproval #IFN #Hematology
💊#FDA Approval Update | FDA approves a new treatment for #EssentialThrombocythemia
#Besremi (#ropeginterferon alfa-2b), a monopegylated IFN-α, is now approved for adults with this rare blood disorder, which causes the bone marrow to produce too many platelets and can increase the risk of blood clots and bleeding.
🔬In the Phase 3 SURPASS ET study:
37.4% of patients receiving Besremi achieved a durable response vs. just 3.6% with #anagrelide.
🧬Stay on top of the latest research, approvals updates & science visuals. Follow @MedChemExpress for more!
#FDAApproval #IFN #RareDisease #BloodDisorders #DrugDevelopment #Biotech
💊#FDA Approval Update | FDA approves a new treatment for #EssentialThrombocythemia
#Besremi (#ropeginterferon alfa-2b), a monopegylated IFN-α, is now approved for adults with this rare blood disorder, which causes the bone marrow to produce too many platelets and can increase the risk of blood clots and bleeding.
🔬In the Phase 3 SURPASS ET study:
37.4% of patients receiving Besremi achieved a durable response vs. just 3.6% with #anagrelide.
🧬Stay on top of the latest research, approvals updates & science visuals. Follow @MedChemExpress for more!
#FDAApproval #IFN #RareDisease #BloodDisorders #DrugDevelopment #Biotech
👀 The #FDA has approved the first treatment for #EssentialThrombocythemia in almost 3️⃣0️⃣ years.
Phase 3 trial data show @PharmaEssentia’s #Besremi produced a clinical response rate of 37.4%, compared with 3.6% with anagrelide. https://t.co/cGeHMYl3xG
BESREMi pen update: Available to order August 7. Thanks to PharmaEssentia for the demo kit. The pen is similar to a GLP-1 pen and may simplify injections for patients who need it. Ask your physician for details.
#BESREMi #polycythemiavera ##bloodcancerawareness
🇪🇸 ¿Cuándo se aprobará #Besremi en España?
📍MPN España (@peter_mpn) participó en el evento de @AOPHealthIberia en Lisboa, reafirmando su compromiso por el acceso equitativo a tratamientos innovadores.
🧩 Firma y comparte:
👉 https://t.co/t6ZwjZfFMb
#MPNsm
#Besremi (ropeginterferon alfa-2b-njft) is the first interferon approved specifically as a treatment for #polycythemia vera.
https://t.co/M47Tquj1f6
New drugs, namely #Vyvgart #Cytalux #Livtencity #Besremi approved in 2021 by FDA showed adverse effects in clinical trials. The adverse effects of these drugs should be analysed & monitored carefully. Read More- https://t.co/UDCdOp1E1W
#MDForLives #sidereactionofdrugs
FDA Approves Ropeginterferon Alfa-2b-njft for Adults With Polcythemia Vera https://t.co/mvTlblgHeQ @targetedoncより
PROUD-PV試験（NCT01949805）とCONTINUATION-PV試験（NCT02218047）に基づく承認
ほしい…
#Besremi
People w/ #polycythemiavera have blood thickened by an overabundance of red blood cells that raise the risk of stroke, heart attack. FDA has approved the 1st drug therapy for the rare blood #cancer, a PharmaEssentia interferon drug called #Besremi. https://t.co/6KbGcrZhOt
Máme další úspěch ve sporu s VZP o mimo��ádnou úhradu léčivého přípravku #Besremi
https://t.co/VlIGmuIdci
Last Seen Hashtags on Sotwe
boşalma
Seen from Turkey
MGAI
Seen from Brazil
30days
Seen from Italy
mgai minichatttt
Seen from Italy
92i()**********************************************************************
Seen from France
bully madre
Seen from Peru
ตลาด200ปี
Seen from Thailand
Teenage creampie
Seen from Canada
colegiala peruana
Seen from Peru
upthespartans
Seen from Israel
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
241M followers
Barack Obama
@barackobama
118.8M followers
Cristiano Ronaldo
@cristiano
114.5M followers
Donald J. Trump
@realdonaldtrump
111.9M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.5M followers
Virat Kohli
@imvkohli
73.4M followers
Kim Kardashian
@kimkardashian
70.8M followers
YouTube
@youtube
68.7M followers
Neymar Jr
@neymarjr
66.4M followers
Bill Gates
@billgates
65.2M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.2M followers
CNN
@cnn
61.7M followers
X
@x
60.6M followers